Related Experiment Video
Updated: Jul 7, 2025

00:09
Semiconductor Sequencing for Preimplantation Genetic Testing for Aneuploidy
Published on: August 25, 2019
9.4K
Isolated polyhydramnios: Is a genetic evaluation of value?
Xiao-Mei Lin1, Li Zhen1, Yun-Jing Wen1
1Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center affiliated to Guangzhou Medical University, Guangzhou, Guangdong, China.
European Journal of Obstetrics, Gynecology, and Reproductive Biology
|December 23, 2023
Summary
Isolated polyhydramnios in pregnancy poses a risk for genetic aberrations. Advanced genetic testing like exome sequencing may offer valuable insights into pregnancy outcomes.
Area of Science:
- Perinatology
- Medical Genetics
- Reproductive Medicine
Background:
- Isolated polyhydramnios is a condition of excessive amniotic fluid without other fetal anomalies.
- The risk of underlying genetic abnormalities in isolated polyhydramnios requires further investigation.
Purpose of the Study:
- To analyze the risk for genetic aberrations in pregnancies with isolated polyhydramnios.
- To evaluate pregnancy outcomes associated with isolated polyhydramnios.
Main Methods:
- Retrospective study of singleton pregnancies with isolated polyhydramnios undergoing genetic amniocentesis (2016-2021).
- Collected data included maternal demographics, sonographic findings, chromosomal microarray results, and pregnancy outcomes.
- Whole exome sequencing was utilized for postnatal diagnosis of single gene disorders.
Main Results:
- Three cases (3.2%) had chromosomal abnormalities, including trisomy 21 and 22q21.1 microdeletion.
- One case of Prader-Willi syndrome and one of Bartter syndrome were identified.
- Postnatal whole exome sequencing identified single gene disorders in two infants.
Conclusions:
- Isolated polyhydramnios is associated with a notable risk of genetic aberrations.
- Advanced genetic testing, including whole exome sequencing, shows potential in identifying genetic causes.
- Further research is warranted to establish the role of advanced genetic technologies in managing isolated polyhydramnios.

